<DOC>
	<DOCNO>NCT00992381</DOCNO>
	<brief_summary>The purpose study determine whether absorption naproxen PN 400 combination ( Naprosyn Esomeprazole ) tablets similar naproxen tablet ( NaprosynÂ® ) , currently sell Australia .</brief_summary>
	<brief_title>Comparison Study New Combination 2 Marketed Medications ( Esomeprazole Naprosyn ) Versus Naprosyn Alone</brief_title>
	<detailed_description />
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Subjects must body weight great 50 kg BMI within range 1830 ( inclusive ) . Subjects must good health , assess prestudy medical examination review screen result Subjects must understand procedure involve agree participate study give fully inform , write consent Significant intercurrent disease type , particular liver , kidney , cardiovascular disease , form diabetes significant gastrointestinal disorder could affect drug absorption , history gastric duodenal ulceration . Ingestion naproxen , omeprazole , esomeprazole relate drug prior recruitment interview , drug ingest 4 week prior day set first Period 1 dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>GI Pain</keyword>
	<keyword>healthy participant</keyword>
	<keyword>Safety</keyword>
	<keyword>bioavailability</keyword>
</DOC>